VAERS reports by lot

Moderna COVID-19 lot 074B22A: VAERS reports

85 VAERS reports list lot 074B22A as a Moderna COVID-19 vaccine, received between 2022-10-04 and 2024-03-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
85
Reports
1%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3328%
Cardiac / Cardiovascular2824%
Neurological1513%
Musculoskeletal119%
Injection-site / Local reaction87%
Gastrointestinal76%
Thrombotic / Hematological54%
Allergic / Anaphylactic33%
Dermatological (non-injection-site)33%
Psychiatric / Neuropsychiatric22%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California8
Washington7
North Carolina5
Louisiana4
New Jersey4
Ohio3
Michigan3
Texas3
Oregon2
Missouri2
Wisconsin2
Puerto Rico2

Reports by month received

2022-1014
2022-118
2022-1212
2023-013
2023-0215
2023-0315
2023-048
2023-053
2023-063
2023-072
2023-081
2024-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.